Brain metastases are diagnosed through a combination of clinical evaluation, imaging studies, and sometimes biopsy. Diagnostic modalities include:
- Clinical Evaluation:
- Neurological Examination: Doctors assess symptoms such as headaches, seizures, changes in mental status, and neurological deficits (e.g., weakness, sensory changes).
- Imaging Studies:
- Magnetic Resonance Imaging (MRI): The most sensitive imaging technique for detecting brain metastases. MRI with contrast enhancement can provide detailed images of brain structures.
- Computed Tomography (CT) Scan: Often used if MRI is not available or feasible. A CT scan with contrast can help identify lesions.
- Positron Emission Tomography (PET) Scan: Sometimes used to detect cancer spread in the body, including the brain.
- Whole-Body Imaging: Often performed to identify the primary tumor and other metastatic sites (e.g., chest CT, abdominal CT).
- Biopsy:
- Stereotactic Biopsy: A minimally invasive procedure where a small sample of the brain lesion is taken for histological examination.
- Surgical Biopsy/Resection: In cases where the lesion is accessible, and surgery is indicated, the tumor can be removed and analyzed.
- Lumbar Puncture:
- Occasionally, cerebrospinal fluid (CSF) analysis may be performed if there is suspicion of leptomeningeal spread (cancer spread to the membranes surrounding the brain and spinal cord).
- Laboratory Tests:
- Blood tests and tumor markers may be used to support the diagnosis and identify the primary cancer.
- Blood tests and tumor markers may be used to support the diagnosis and identify the primary cancer.
